Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma.
Damanti CC, Ferrone L, Gaffo E, Garbin A, Tosato A, Contarini G, Gallingani I, Angioni R, Molon B, Borile G, Carraro E, Pillon M, Scarmozzino F, Dei Tos AP, Pizzi M, Ciscato F, Rasola A, Biffi A, Bortoluzzi S, Lovisa F, Mussolin L. Damanti CC, et al. Among authors: gallingani i. Cancer Commun (Lond). 2023 May;43(5):630-634. doi: 10.1002/cac2.12415. Epub 2023 Apr 4. Cancer Commun (Lond). 2023. PMID: 37014813 Free PMC article. No abstract available.
Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology.
Di Battista P, Lovisa F, Gaffo E, Gallingani I, Damanti CC, Garbin A, Ferrone L, Carraro E, Pillon M, Lo Nigro L, Mura R, Pizzi M, Guzzardo V, Dei Tos AP, Biffi A, Bortoluzzi S, Mussolin L. Di Battista P, et al. Among authors: gallingani i. Front Oncol. 2021 May 25;11:663221. doi: 10.3389/fonc.2021.663221. eCollection 2021. Front Oncol. 2021. PMID: 34113568 Free PMC article.
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma.
Garbin A, Lovisa F, Holmes AB, Damanti CC, Gallingani I, Carraro E, Accordi B, Veltri G, Pizzi M, d'Amore ESG, Pillon M, Biffi A, Basso K, Mussolin L. Garbin A, et al. Among authors: gallingani i. Haematologica. 2021 Feb 1;106(2):610-613. doi: 10.3324/haematol.2019.241307. Haematologica. 2021. PMID: 32299901 Free PMC article. No abstract available.
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
Veltri G, Silvestri C, Gallingani I, Sandei M, Vencato S, Lovisa F, Cortese G, Pillon M, Carraro E, Bresolin S, Biffi A, Basso G, Accordi B, Mussolin L, Serafin V. Veltri G, et al. Among authors: gallingani i. Cancers (Basel). 2021 Jul 24;13(15):3724. doi: 10.3390/cancers13153724. Cancers (Basel). 2021. PMID: 34359628 Free PMC article.
Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration.
Mussolin L, Lovisa F, Gallingani I, Cavallaro E, Carraro E, Damanti CC, Vinti L, Sala A, Micalizzi C, Santoro N, Piglione M, Cellini M, Buffardi S, Buldini B, D'Amore ESG, Biffi A, Pillon M. Mussolin L, et al. Among authors: gallingani i. Br J Haematol. 2020 May;189(3):e108-e111. doi: 10.1111/bjh.16531. Epub 2020 Feb 20. Br J Haematol. 2020. PMID: 32080837 Free article. No abstract available.
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.
Lovisa F, Gallingani I, Varotto E, Pasin C, Carraro E, Michielotto B, Garbin A, Damanti CC, Pizzi M, d'Amore ESG, Piglione M, Muggeo P, Buffardi S, Vinti L, Folsi VM, Onofrillo D, Biffi A, Buldini B, Pillon M, Mussolin L. Lovisa F, et al. Among authors: gallingani i. Diagnostics (Basel). 2021 Sep 1;11(9):1594. doi: 10.3390/diagnostics11091594. Diagnostics (Basel). 2021. PMID: 34573936 Free PMC article.
Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers?
Lovisa F, Garbin A, Crotti S, Di Battista P, Gallingani I, Damanti CC, Tosato A, Carraro E, Pillon M, Mafakheri E, Romanato F, Gaffo E, Biffi A, Bortoluzzi S, Agostini M, Mussolin L. Lovisa F, et al. Among authors: gallingani i. Diagnostics (Basel). 2021 Feb 6;11(2):253. doi: 10.3390/diagnostics11020253. Diagnostics (Basel). 2021. PMID: 33562105 Free PMC article.